Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 25 X posts from 18 X users, with an upper bound of 83,260 followers.

RT @jitcancer: Eduardo Castanon of @ClinicaNavarra provides an update on IT MEDI1191 + durvalumab, a first-in-human study in advanced solid…

RT @jitcancer: Eduardo Castanon of @ClinicaNavarra provides an update on IT MEDI1191 + durvalumab, a first-in-human study in advanced solid…

RT @jitcancer: Eduardo Castanon of @ClinicaNavarra provides an update on IT MEDI1191 + durvalumab, a first-in-human study in advanced solid…

RT @jitcancer: Eduardo Castanon of @ClinicaNavarra provides an update on IT MEDI1191 + durvalumab, a first-in-human study in advanced solid…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 21 additional X posts.